Reported Reactions

Devices › Device types

FDA product code PDU · class 2 · Cardiovascular

Catheter for crossing total occlusions: medical device reports filed with FDA

1,386 reports carry this product code, 2013–2026; 6 brands with a page.

1,386
reports with this product code
0% of all MAUDE reports
192
reports, 12 months to August 2026
151 in the 12 months before
90.3%
classified as malfunction
62.3% across all reports
0.1%
classified as death, as reported
0.9% across all reports

Product code PDU is FDA's classification for "Catheter for crossing total occlusions" (cardiovascular panel), a class 2 device. 1,386 medical device reports carry this product code, 0% of the MAUDE database, from November 2013 to August 2026.

192 reports arrived in the 12 months to August 2026, up 27% from 151 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (90.3%), injury (9.5%) and death (0.1%). 6 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Crosser361570%97%
Crosser Cto Recanalization Catheter25600.3%92%
Crosser Cto Recanalization Catheters21000%93.7%
Crosser Recanalization Catheter1401.3%81.8%
Outback Re-Entry Catheter300%84%
Bd101%56%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Bard Peripheral Vascular1,03374.5%
Cordis805.8%
Volcano493.5%
Cordis De Mexico201.4%
Baylis Medical120.9%
Cordis US10.1%
Spectranetics10.1%

Reports by month, five years

01326Sep 2021: 15Oct 2021: 17Nov 2021: 13Dec 2021: 142022Jan 2022: 13Feb 2022: 17Mar 2022: 15Apr 2022: 14May 2022: 14Jun 2022: 15Jul 2022: 15Aug 2022: 14Sep 2022: 7Oct 2022: 8Nov 2022: 10Dec 2022: 142023Jan 2023: 7Feb 2023: 13Mar 2023: 13Apr 2023: 8May 2023: 7Jun 2023: 2Jul 2023: 5Aug 2023: 6Sep 2023: 2Oct 2023: 5Nov 2023: 2Dec 2023: 12024Jan 2024: 1Feb 2024: 3Mar 2024: 9Apr 2024: 7May 2024: 10Jun 2024: 8Jul 2024: 11Aug 2024: 7Sep 2024: 10Oct 2024: 5Nov 2024: 13Dec 2024: 82025Jan 2025: 12Feb 2025: 15Mar 2025: 19Apr 2025: 17May 2025: 14Jun 2025: 9Jul 2025: 15Aug 2025: 14Sep 2025: 10Oct 2025: 16Nov 2025: 26Dec 2025: 152026Jan 2026: 14Feb 2026: 18Mar 2026: 18Apr 2026: 18May 2026: 23Jun 2026: 11Jul 2026: 7Aug 2026: 16

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0.1%2
Injury9.5%131
Malfunction90.3%1,252
Other0%0
Not given0.1%1

Who filed

Manufacturer report97.9%1,357
Voluntary report1.3%18
User facility report0%0
Distributor report0%0
Not given0.8%11

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Material separation65147%
Detachment of device or device componentpart of the device came off33724.3%
Fracturea broken bone1379.9%
Device-device incompatibility1369.8%
Retraction problem1128.1%
Material deformation916.6%
Breakthe device broke896.4%
Failure to advance664.8%
Material twisted/bent644.6%
Material split, cut or torn614.4%
Activation problem453.2%
Difficult to removethe device was hard to remove453.2%
Leak/splashthe device leaked322.3%
Entrapment of device251.8%
Torn material251.8%
Material frayed241.7%
Peeled/delaminated241.7%
Device inoperablethe device could not be used191.4%
Material puncture/hole191.4%
Overheating of device181.3%

Questions about catheter for crossing total occlusions reports

What is product code PDU?

FDA's classification code for "Catheter for crossing total occlusions", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.

How many reports carry this code?

1,386 reports through August 2026, 192 of them in the latest 12 months.

Which brands appear most often?

Crosser (361), Crosser Cto Recanalization Catheter (256), Crosser Cto Recanalization Catheters (210), Crosser Recanalization Catheter (14) and Outback Re-Entry Catheter (3). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.